Citius Pharmaceuticals, Inc. (CTXR)
0.5817
-0.02
(-3.37%)
USD |
NASDAQ |
Sep 04, 16:00
0.5817
0.00 (0.00%)
After-Hours: 19:14
Citius Pharmaceuticals Total Liabilities (Quarterly) : 66.35M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.35M |
| March 31, 2026 | 63.46M |
| December 31, 2025 | 46.92M |
| September 30, 2025 | 53.63M |
| June 30, 2025 | 60.12M |
| March 31, 2025 | 57.91M |
| December 31, 2024 | 51.78M |
| September 30, 2024 | 42.55M |
| June 30, 2024 | 10.81M |
| March 31, 2024 | 10.74M |
| December 31, 2023 | 12.07M |
| September 30, 2023 | 12.18M |
| June 30, 2023 | 12.10M |
| March 31, 2023 | 12.43M |
| December 31, 2022 | 10.67M |
| September 30, 2022 | 10.57M |
| June 30, 2022 | 9.980M |
| March 31, 2022 | 9.59M |
| December 31, 2021 | 12.96M |
| September 30, 2021 | 9.646M |
| June 30, 2021 | 9.311M |
| March 31, 2021 | 8.904M |
| December 31, 2020 | 9.511M |
| September 30, 2020 | 10.10M |
| June 30, 2020 | 9.658M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.049M |
| December 31, 2019 | 4.606M |
| September 30, 2019 | 4.608M |
| June 30, 2019 | 4.038M |
| March 31, 2019 | 3.361M |
| December 31, 2018 | 3.900M |
| September 30, 2018 | 3.185M |
| June 30, 2018 | 2.190M |
| March 31, 2018 | 2.562M |
| December 31, 2017 | 2.617M |
| September 30, 2017 | 2.469M |
| June 30, 2017 | 9.973M |
| March 31, 2017 | 7.342M |
| December 31, 2016 | 6.319M |
| September 30, 2016 | 5.184M |
| June 30, 2016 | 4.854M |
| March 31, 2016 | 4.353M |
| December 31, 2015 | 1.937M |
| September 30, 2015 | 1.377M |
| June 30, 2015 | 2.143M |
| March 31, 2015 | 1.684M |
| December 31, 2014 | 1.646M |
| September 30, 2014 | |
| June 30, 2014 | 0.0314M |
| March 31, 2014 | 0.0251M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Citius Oncology, Inc. | 71.71M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.26M |
| Shareholders Equity (Quarterly) | 66.61M |
| Debt to Equity Ratio | 0.1077 |
| Current Ratio | 0.839 |
| Net Debt Paydown Yield | -7.53% |